Similar articles

• A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.

  Elwood PC, Cochrane AL, Burr ML, Sweetnam PM, Williams G, Welsby E, Hughes SJ, Renton R. Elwood PC, et al. Br Med J. 1974 Mar 9;1(5905):436-40. doi: 10.1136/bmj.1.5905.436. Br Med J. 1974. PMID: 4593555 Free PMC article. Clinical Trial.
• Editorial: Aspirin and atherosclerosis.

  [No authors listed] [No authors listed] Br Med J. 1974 Mar 9;1(5905):408. Br Med J. 1974. PMID: 4816851 Free PMC article. No abstract available.
• Aspirin and recurrent myocardial infarction.

  Jones RJ. Jones RJ. JAMA. 1980 Aug 15;244(7):667-8. JAMA. 1980. PMID: 6993715 Clinical Trial. No abstract available.
• [Evaluation of the results of using aspirin in preventing recurrence of myocardial infarct].

  Halawa B, Mazurek W. Halawa B, et al. Wiad Lek. 1981 Oct 1;34(19):1621-6. Wiad Lek. 1981. PMID: 7039141 Review. Polish. No abstract available.
• Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.

  Polli EE, Cortellaro M. Polli EE, et al. Haematologica. 1980 Jun;65(3):361-9. Haematologica. 1980. PMID: 6778788 Review. No abstract available.